We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Cannabinoid Technologies Holdings Plc | LSE:OCTP | London | Ordinary Share | GB00BMVMRB86 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.115 | 0.10 | 0.13 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 0 | -5.95M | -0.0062 | -0.18 | 1.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/5/2023 09:06 | Funding is OK till first quarter 2024 | jayrh | |
17/5/2023 08:20 | Here we go | inaminute | |
17/5/2023 07:58 | Moving up again 2p afternoon | zxie | |
17/5/2023 07:47 | trolls are out...talking bs...interview later...2p COP | jambam | |
17/5/2023 07:37 | Looking forward Q3 | zxie | |
17/5/2023 07:33 | Placing is the next news I suspect. | paulscb | |
17/5/2023 07:28 | Market doesn't seem too happy with this really good news!!Why? | billthebank | |
17/5/2023 07:14 | Loading time | zxie | |
17/5/2023 07:14 | Over 2p today | zxie | |
17/5/2023 07:07 | I stand corrected ... you were touting PERE ... I only popped my head in there yesterday ;) | g2theary | |
17/5/2023 07:05 | Sell on news | jameshendrix2023 | |
17/5/2023 07:01 | 2p+ ... get in Jimmy :O | g2theary | |
17/5/2023 06:59 | Gamechanging RNS | gotterdammerung | |
17/5/2023 06:58 | Show me a post where i was buying nnn | jameshendrix2023 | |
17/5/2023 06:51 | This guy will move it up ;) | g2theary | |
17/5/2023 06:50 | Someone missed out :) after reading when you were buying NNN I'll make my own decisions :D | g2theary | |
17/5/2023 06:38 | SellOn news it will be Be carefulBuying the spike | jameshendrix2023 | |
17/5/2023 06:09 | Very cool job | zxie | |
17/5/2023 06:09 | OCTP is pleased to announce that the Medicines and Healthcare Products Regulatory Agency ("MHRA") and the Wales Research Ethics Committee 2 ("REC 2") have approved the Company's combined Phase I clinical trial application for OCTP's lead drug candidate, OCT461201 . | zxie | |
17/5/2023 06:04 | Finally :-))))))) | pillow | |
16/5/2023 13:50 | RNS on the way | zxie | |
16/5/2023 13:26 | Fancy a big fund raise with the news yum yum | itscominghome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions